×
For best experience we recommend to activate Javascript in your browser.
TXNDC3/NME8 antibody (AA 530-587)
The Mouse Monoclonal anti-TXNDC3/NME8 antibody (Clone 1G5) (ABIN2380686) specifically detects TXNDC3/NME8 in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN2380686
$905.21
Plus shipping costs $50.00
Delivery in 11 to 16 Business Days
Quick Overview for TXNDC3/NME8 antibody (AA 530-587) (ABIN2380686)
Target
See all TXNDC3/NME8 (TXNDC3) Antibodies
TXNDC3/NME8 (TXNDC3)
(Thioredoxin Domain Containing 3 (TXNDC3))
Reactivity
All reactivities for TXNDC3/NME8 antibodies
Human
Host
All hosts for TXNDC3/NME8 antibodies
Mouse
Clonality
All clonalities for TXNDC3/NME8 antibodies
Monoclonal
Conjugate
All conjugates for TXNDC3/NME8 antibodies
This TXNDC3/NME8 antibody is un-conjugated
Application
All applications for TXNDC3/NME8 antibodies
ELISA, Western Blotting (WB)
Clone
1G5
Product Details anti-TXNDC3/NME8 Antibody
(hide)
Binding Specificity
All epitopes for TXNDC3/NME8 antibodies
AA 530-587
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
TXNDC3 (Thioredoxin Domain-containing Protein 3, CILD6, NM23-H8, NME/NM23 Family Member 8, NME8, Spermatid-specific Thioredoxin-2, SPTRX2, Sptrx-2)
Purification
Purified by Protein A affinity chromatography.
Immunogen
Partial recombinant corresponding to aa530-587 from human TXNDC3 (NP_057700) with GST tag. MW of the GST tag alone is 26kD.
Isotype
IgG2a kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2.
Storage
-20 °C
Storage Comment
-20°C
Target Details for TXNDC3/NME8
(hide)
Target
TXNDC3/NME8 (TXNDC3)
(Thioredoxin Domain Containing 3 (TXNDC3))
Alternative Name
TXNDC3
NCBI Accession
NM_016616 , NP_057700
Pathways
Nucleotide Phosphorylation , Ribonucleoside Biosynthetic Process , Cell RedoxHomeostasis
Recently viewed
(hide)
Chat with us , powered by LiveChat